首页> 外文期刊>Vox Sanguinis: International Journal of Blood Transfusion and Immunohaematology >International reference reagents to standardise blood group genotyping: Evaluation of candidate preparations in an international collaborative study
【24h】

International reference reagents to standardise blood group genotyping: Evaluation of candidate preparations in an international collaborative study

机译:标准化血型基因型的国际参考试剂:在国际合作研究中评估候选制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objectives The aim of the study was to evaluate, in an international collaboration, four lyophilised genomic DNA preparations, selected from genotyped and phenotyped donors by the study organisers, for their suitability to standardise and control blood group genotyping procedures for common ancestral Caucasian and Black African alleles. Materials and Methods Twenty-nine laboratories performed 'blind' testing of replicated ampoules of the candidate reference reagents, RBC1 (10/232), RBC4 (10/236), RBC5 (10/238) and RBC12 (10/234), using a range of genotyping procedures, most commonly classical PCR using allele or sequence specific primers. Results The majority of laboratories reported blood group genotypes in accordance with those determined by the study organisers and the serological phenotypes. Despite an overall high level of accuracy in genotyping, the identified errors and inconsistencies, and the limited genotyping capabilities of many laboratories, confirmed the need for validated reference materials to control test procedures. Conclusions The establishment of RBC1, RBC4, RBC5 and RBC12 as World Health Organization Reference Reagents will facilitate international standardisation of blood group genotyping and ensure that such tests are sufficiently sensitive and specific.
机译:背景与目的本研究的目的是在国际合作下评估研究组织者从基因型和表型供体中选择的四种冻干基因组DNA制剂是否适合标准化和控制普通祖先高加索人和普通人的血型基因分型程序。非洲黑人等位基因。材料和方法29个实验室使用以下方法对候选参考试剂RBC1(10/232),RBC4(10/236),RBC5(10/238)和RBC12(10/234)的复制安瓿瓶进行了“盲”测试。一系列基因分型程序,最常见的是使用等位基因或序列特异性引物的经典PCR。结果大多数实验室报告的血型基因型与研究组织者确定的血型和血清型有关。尽管基因分型总体上具有很高的准确性,但已鉴定出的错误和不一致之处以及许多实验室的基因分型能力有限,这证实了需要经过验证的参考材料来控制测试程序。结论建立RBC1,RBC4,RBC5和RBC12作为世界卫生组织参考试剂将促进血型基因分型的国际标准化,并确保此类测试足够灵敏和特异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号